Disclosure Panels Details Page
Occult Primary Panel - Disclosures as of 04/19/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Daniel Ahn DO | AstraZeneca Pharmaceuticals LP Bayer HealthCare |
Advanced Accelerator Applications | None | None | ✔ |
| Salwan Al Mutar MD, MS | None | None | None | None | ✔ |
| David Bajor MD | Astellas Pharma US, Inc. Rafael Pharmaceuticals Seattle Genetics, Inc. TESARO, Inc. |
None | Cardinal Health | None | - |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| Daniel Bowles MD | None | Blueprint Medicines Exelixis Inc. |
None | None | ✔ |
| Sam Brondfield MD, MA | None | None | American Physician Institute Blackstone Doximity Pharmaceutical Associates, Inc. System Analytic |
None | ✔ |
| Julie Bykowski MD | None | None | None | None | ✔ |
| Scott Christensen MD | None | None | ASCO AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Daiichi- Sankyo Co. Regeneron Pharmaceuticals, Inc. |
None | ✔ |
| Eileen Cucinotta | None | None | None | None | ✔ |
| Jeremiah Deneve DO | None | None | None | None | - |
| Keith Eaton MD, PhD | Mirati Therapuetics | Eli Lilly and Company | None | None | ✔ |
| David Ettinger MD, FACP, FCCP | None | Beyond Spring Pharmaceuticals | None | None | ✔ |
| David Gierada MD | Delfi Diagnostics, Inc. | None | None | None | ✔ |
| G. Weldon Gilcrease MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Angela Jain MD | None | None | None | None | ✔ |
| Aparna Kalyan MD | None | Incyte Corporation | Exelixis Inc. | None | ✔ |
| Zachary Kohutek MD, PhD | None | None | None | None | ✔ |
| Christina Kong MD | None | Neil, Dymott, Frank, McCabe & Hudson | None | None | ✔ |
| Jeremy Kortmansky MD | None | None | None | None | ✔ |
| John Kosteva MD | None | None | AstraZeneca Pharmaceuticals LP Bayer HealthCare Boehringer Ingelheim GmbH |
AbbVie, Inc.|Bristol Myers Squibb|Merck & Co., Inc. | ✔ |
| Renato Lenzi MD | None | None | None | None | ✔ |
| Sam Lubner MD | Agios, Inc. Bristol Myers Squibb Histosonics |
Elephas Biosciences | None | Elephas Biosciences | ✔ |
| Alissa Marr MD | None | None | None | None | ✔ |
| Beth McCullough RN, BS, CMSRN | None | None | None | None | ✔ |
| Sarbajit Mukherjee MD, MS | None | None | None | None | ✔ |
| Darryl Outlaw MD | None | None | OncLive - Institutional Perspectives in Cancer: Gastrointestinal Malignancies | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | ✔ |
| Anuj Patel MD | None | None | None | None | ✔ |
| Bradford Perez MD | Bristol Myers Squibb EMD Serono G1 Therapeutics H Lee Moffitt Cancer Center and Research Institute NRG |
None | None | None | ✔ |
| John Phay MD | None | Ai Biomed | None | None | ✔ |
| Lenora Pluchino PhD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Asif Rashid MD | None | None | None | None | ✔ |
| Kerry Reynolds MD | Project DataSphere | None | None | None | ✔ |
| Lee Rosen MD | ATLAS PHARMACEUTICALS Bayer HealthCare BeiGene Deciphera Pharmaceuticals, Inc. ISOFOL PHARMA Kadmon NGM PHARMA Novartis Pharmaceuticals Corporation Oxford Pfizer Inc. PSIOXUS PHARMA RasCal RGX PHARMA Senhwa Taiho Pharmaceuticals Co., Ltd. |
None | None | None | - |
| Leonard Saltz MD | None | Genor Biopharma | None | None | ✔ |
| Jeffrey Smerage MD, PhD | sanofi-aventis U.S. | None | None | None | ✔ |
| Marvaretta Stevenson MD | None | None | None | None | ✔ |
| Daphne Stewart MD, MS | None | None | None | None | ✔ |
| Bettyanne Sunderland BSN, OCN | None | None | None | None | ✔ |